ORKA Q2 2021 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$19,000

Operating Income

-$5M

Net Income

-$5M

EPS (Diluted)

$-4.03

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$65M

Total Liabilities

$4M

Stockholders' Equity

$61M

Cash & Equivalents

$63M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$19,000	-$26,000	+26.9%
Operating Income	-$5M	-$1M	-269.2%
Net Income	-$5M	-$1M	-271.3%